Background
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, with a high morbidity and mortality rate [
1,
2]. Surgical resection is identified as the most effective therapy for HCC treatment, but high recurrence and distant metastasis after surgery result in poor prognosis of HCC [
3,
4]. Exosomes play important roles in multiple aspects of HCC, which include angiogenesis, chemoresistance and metastasis [
5]. Moreover, some exosome biomarkers are used for the early diagnosis and prognosis of HCC patients [
6,
7]. Cancer cell-secreted exosomes were considered as important messengers in intercellular communication, thus many studies have unveiled the function of exosome in tumor microenvironment [
8]. Nevertheless, few studies have addressed the underlying molecular mechanisms of tumor cell secretion of exosomes.
Exosomes are 30–150 nm nano-sized vesicles containing various types of nucleic acids, such as proteins, RNAs and lipids [
9]. Exosome biogenesis is formed by the budding of multivesicular body (MVB) membranes inwards to shape intra-luminal vesicles, ultimately maturing and contained within MVBs [
10]. Multiple effectors and molecular mechanisms are involved in regulating the intracellular trafficking steps such as MVB movement, docking, and integration of exosomes with the plasma membrane before release [
11]. Rab GTPases are responsible for regulating MVB motility and plasma membrane docking [
12]. The Rab family contains many subtypes, and some Rab GTPases are crucial mediators in modulating exosome secretion, such as Rab27A and Rab27B. Rab27A and Rab27B have been reported to be the primary components of vesicle trafficking in exosome secretion and play critical roles in tumor progression and metastasis [
13]. Nevertheless, the mechanisms by which Rab GTPases control the secretion of exosome in HCC cells remain to be further investigated.
According to global gene expression data in mammalian species, the majority of the genome is transcribed into non-coding RNAs (ncRNAs) [
14]. Long non-coding RNA (lncRNA) is a class of ncRNAs greater than 200 nucleotides in length, and has been emerged as pivotal regulators in cancer progression [
15]. LncRNAs can regulate gene expression through transcriptional regulation, post-transcriptional regulation, chromatin modification as well as genomic imprinting [
16]. Aberrantly expressed lncRNAs can participate in HCC progression as oncogenes or tumor suppressors [
17]. MCM3AP-AS1 exerts an oncogenic role in HCC progression via interacting with miR-194-5p to elevate FOXA1 expression [
18]. MAGI2-AS3 impedes cell proliferation and migration in HCC via the miR-374b-5p/SMG1 axis [
19]. LncRNA PRR34 long non-coding RNA antisense RNA 1 (PRR34-AS1) regulates HCC cells malignant phenotypes through miR-296-5p/SOX12/E2F2 axis [
20] or miR-498/TOMM20/ITGA6 axis [
21].
In this study, to further reveal the effect of PRR34-AS1 in HHC, we probed into the role of PRR34-AS1 in HCC, and investigated the mechanism between HCC cells and THLE-3 cell by exosome secretion. Our study might offer a novel sight for HCC treatment.
Methods
Cell culture
HCC cells including HLF, Huh-7, SNU-449, HepG2 and LM3 were obtained from COBIOER (Nanjing, China). HLF, Huh-7 and LM3 cells were grown in DMEM. SNU-449 cells were grown in RPMI-1640 medium. HepG2 cells were grown in MEM. All mediums were obtained from Gibco (Grand Island, USA). Human liver epithelial cell (THLE-3) was obtained from ATCC (Manassas, VA, USA) and kept in BEGM (Lonza/Clonetics Corporation, Walkersville). Cells were left to grow at 37 °C under a humid environment with 5% CO2.
Quantitative real-time PCR (RT-qPCR)
Total RNAs were extracted with the application of Trizol reagent (Invitrogen, USA). For the evaluation of gene expression, cDNA was synthesized with the application of PrimeScript RT master mix (Takara, Japan). Next, SYBR Green PCR Master Mix (Applied biosystems) was utilized to conduct qPCR with 2−△△CT calculation. GAPDH served as control.
Cell transfection
Specific shRNAs targeting PRR34-AS1 (sh/PRR34-AS1), as well as DDX3X (sh/DDX3X), Rab27a (sh/Rab27a) and negative control (sh/NC) were synthesized by Genechem (Shanghai, China). Besides, NC or PRR34-AS1 or Rab27a were obtained from RiboBio (Guangzhou, China). Cells were collected for further experiments after 48 h of transfection.
5-Ethynyl-2′-deoxyuridine (EdU)
Cell proliferation was assessed with the application of EdU kit (RiboBio, Guangzhou, China). Cells in 96-well plates were incubated to 90% confluence, and then cultured with 100 μL of 50 μM EdU diluent for 2 h. After fixation with 4% paraformaldehyde and 0.5% Triton X-100 treatment, cells were incubated in the dark with 100 μL of 1× Apollo® staining reaction. DAPI was applied for nuclear redyeing. Images were acquired by a laser confocal microscope.
Cells were planted into 6-well plates (600 cells/well) for 2 weeks, followed by the treatment of 4% paraformaldehyde and 0.5% crystal violet. Finally, the number of colonies (> 50 cells) was counted.
Wound healing
Cells were planted into 6-well plates until completely adhered to the wall, and then cells were scratched for cell culture. Images of wound healing were obtained at 0 h and 24 h after scratching, and the relative wound width was calculated.
Transwell
Transwell chambers (8-μm pores, Corning, USA) pre-coated with Matrigel (BD, USA) were used for invasion assay. Cells were planted into the upper chamber, and the bottom chamber was filled with medium containing 10% FBS. After 24 h of incubation, cells were removed from the upper surface, and the invaded cells were subjected to the fixation with 4% paraformaldehyde for 10 min at room temperature, and stained in 0.5% crystal violet. The average number of invaded cells per field was assessed using a microscope.
Western blot
Cells were cultured in RIPA buffer (Beyotime) for the extraction of proteins. BCA protein assay kit II (Beyotime) was performed for determining protein concentrations. The extracted proteins were subjected to the separation on 10% SDS-PAGE and then transferred onto PVDF membrane (Invitrogen), followed by being blocked with 3% BSA. Blots were incubated overnight at 4 °C with antibodies against E-cadherin (1/1000), N-cadherin (1/1000), Vimentin (1/1000), Slug (1/1000), Twist (1/1000), GAPDH (1/1000), CD9 (1/2000), CD63 (1/2000), HSP70 (1/1000), TSG101 (1/1000), DDX3X (1/1000), VEGF (1/1000), TGF-β (1/1000) and Rab27a (1/1000) and all these antibodies were procured from Abcam. Next, blots were incubated with horseradish peroxidase (HRP)-labeled secondary antibodies. The blot signals were measured through enhanced chemiluminescence reagents.
Immunofluorescence staining
Cells were treated with 4% paraformaldehyde and 0.5% Triton X-100 for fixation and permeabilization, and then blocked in 3% bovine serum albumin. Subsequently, cells were cultured overnight at 4 °C with primary antibodies and cultured for 1 h at 37 °C with specific secondary antibodies. After washing, DAPI was utilized for nuclear redyeing. The images of Immunofluorescence staining were obtained under a confocal microscope.
Exosome isolation
Exosomes were separated from cells using Ribo exosome isolation reagent (RiboBio, Guangzhou, China) based on the user manual. Cells were centrifuged at 2000×g for 30 min, and mixed with Ribo exosome solution reagent. The mixtures were refrigerated at 4 °C overnight, followed by centrifugation at 1500×g for 30 min. Exosomes were obtained after removing the supernatants.
Exosome labeling
PKH67 (1 μM, Sigma-Aldrich) was commercially obtained to label the exosomes according to the supplier’s protocol. Cell nuclear was double-stained by DAPI. Images were observed under a laser scanning microscope.
Nanoparticle tracking analysis (NTA)
The concentration and distribution of exosome size was measured using ZetaView PMX 10 (Particle Metrix, Germany). Exosomes were re-suspended in granular PBS and added to the instrument. Each sample was recorded in 5 videos to confirm the numbers and size distribution of exosomes.
Transmission electron microscopy (TEM)
Cells were centrifuged and treated with 2.5% glutaraldehyde and then treated by osmium tetroxide. Next, cells were embedded with epoxy resin and cut into sections at a thickness of 100 nm, followed by the treatment of uranyl acetate and lead citrate. The images of microscopic samples were captured using a transmission electron microscope.
Fluorescence in situ hybridization (FISH)
Cy3-labeled PRR34-AS1 probe was synthesized (RiboBio, Guangzhou, China). A FISH Kit (RiboBio) was applied for assessing the subcellular localization of PRR34-AS1 base on the manufacturer’s instructions.
Subcellular fractionation
Subcellular isolation of RNAs was performed with the application of Cytoplasmic and Nuclear RNA Purification Kit which was procured from Norgen (Thorold, ON, Canada). Nuclear and cytoplasmic fractions were measured via RT-qPCR.
Luciferase reporter assay
For Rab27a promoter analyses, the sequence of Rab27a promoter was firstly sub-cloned into pGL3-basic reporter vectors (Promega, Madison, WI, USA). After the co-transfection of downregulated PRR34-AS1 and plasmids, the activity of Rab27a promoter was evaluated using a luciferase assay kit (Promega).
RNA-binding protein immunoprecipitation (RIP)
Magna RNA-binding protein immunoprecipitation kit (Millipore, USA) was utilized to assess the binding between RNAs. Cell lysates were cultured with RIP buffer and antibodies (anti-Ago2, anti-SNRNP70 and anti-DDX3X) conjugated with magnetic beads for 1 h. The enrichment of RNAs was evaluated by RT-qPCR.
RNA pull down assay
Pierce Magnetic RNA–Protein Pull-down kit (Thermo fisher scientific) was used in this assay in the light of supplier’s instructions. PRR34-AS1 sense and PRR34-AS1 antisense were in vitro transcripted and labeled. Biotin-labeled PRR34-AS1 (50 pmol) was cultured with streptavidin magnetic beads (50 μL) with rotation, and then hatched in cell lysates. The eluted proteins were measured by western blot after mass spectrometry.
Actinomycin D assay
After reaching 80% confluence, cells were treated with actinomycin D (4 µg/mL, Sigma-Aldrich, USA) to inhibit transcription. The relative mRNA levels were analyzed by RT-qPCR at the indicated time points.
Statistical analysis
Data were processed by GraphPad Prism 6.0 Software and displayed as means ± standard deviation of three replicates. The Student’s t-test and two-way ANOVA were used to analyze differences between two groups or more than two groups. Data were defined as statistical significance if P < 0.05.
Discussion
In this research, we verified that lncRNA PRR34-AS1 recruited DDX3X to stabilize Rab27a mRNA and thereby promoted cell proliferative, migratory, invasive and EMT phenotypes in HCC. Meanwhile, PRR34-AS1 up-regulated Rab27a expression to increase the exosome secretion of VEGF and TGF-β in HCC cells and transmitted them into THLE-3 cells to accelerate the malignant phenotypes of THLE-3 cells. Our study revealed a novel function of PRR34-AS1 in regulating exosome secretion from HCC cells to THLE-3 cells, which provides a promising method for HCC treatment.
In recent years, lncRNAs have emerged as a pivot in the field of cancer research. LncRNA-D16366 is lowly expressed in HCC and might be an independent diagnostic and prognostic indicator for HCC [
23]. RGMB-AS1 plays as a tumor suppressing role in HCC and is an independent favorable prognostic factor for patients with this disease [
24]. All above studies demonstrated the anti-cancer effects of lncRNAs in HCC. In our research, we proved the oncogenic effect of lncRNA PRR34-AS1 in HCC. Furthermore, PRR34-AS1 exhibited a high expression level in HCC. PRR34-AS1 knockdown inhibited HCC cell proliferative, migratory, invasive and EMT abilities. Taken together, lncRNAs play an important role in the regulation of HCC progression.
Our study also found that PRR34-AS1 overexpression facilitated THLE-3 cell malignant phenotypes, suggesting the possibility of exosomes in HCC cells. Exosome-mediated communication in the tumor microenvironment contributes to HCC progression [
5]. Exosome-transmitted lncRNA SENP3-EIF4A1 inhibits cell migration and invasion in HCC [
25]. High expression of exosomal H19 enhances the proliferation and motility of HCC cells [
26]. All these evidence suggested the regulation of exosomal lncRNA in HCC progression. In our study, we confirmed that the capacities of proliferation, migration, invasion and EMT were increased in THLE-3 cells co-cultured with HCC cells as well as in THLE-3 cells treated with HCC-secreted exosomes. However, PRR34-AS1 expression was not affected in THLE-3 cells co-cultured with HCC cells as well as in THLE-3 cells treated with HCC-secreted exosomes, which ruled out the existence of exosomal PRR34-AS1 in HCC.
As we all know, exosomes are a type of secretory membrane vesicle with the structural and biochemical characteristics of multivesicular endosomes [
27]. Several Rab GTPases, including Rab27a, Rad27b, and Rab35, were previously found to play a crucial role in regulating exosome secretion and influencing cellular process [
28]. It has been reported that lncRNA HOTAIR motivates exosome secretion via mediating RAB35 and SNAP23 in HCC [
29]. In our study, we demonstrated that PRR34-AS1 silencing obviously reduced the expression of Rab27a. It has been reported that KIBRA modulates exosome secretion via repressing the proteasomal degradation of Rab27a [
30]. All above results uncovered that PRR34-AS1 regulated Rab27a to affect exosome secretion in HCC cells.
Moreover, our study found that PRR34-AS1 interacted with DDX3X to regulate the stability of Rab27a mRNA. In line with our study, HHIP-AS1 inhibits HCC progression through recruiting HUR to stabilize HHIP mRNA [
31]. FAM83A-AS1 expedites HCC progression by interacting with NOP58 to increase the mRNA stability of FAM83A [
32]. After confirming the regulatory mechanism between PRR34-AS1 and Rab27a, we revealed that Rab27a accelerated cell malignant phenotypes in THLE-3 cells. More importantly, Rab27a up-regulation also promoted exosome secretion of VEGF and TGF-β, suggesting that PRR34-AS1 regulated Rab27a to promote the exosome secretion of VEGF and TGF-β and thereby transmitted them into THLE-3 cells to accelerate cell malignant phenotypes.
However, our study had some limitations. We didn’t unravel the detailed mechanism of Rab27a on regulating exosome secretion of VEGF and TGF-β, which will be addressed in the future.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.